Prognostic and predictive covariates in limited-stage small-cell lung cancer: analysis of the phase 3 CONVERT trial
Affiliation
Division of Cancer Sciences, University of Manchester, Manchester/GBIssue Date
2018
Metadata
Show full item recordCitation
Salem A, Mistry H, Falk S, Faivre-Finn C. P2.12-15 Prognostic and predictive covariates in limited-stage small-cell lung cancer: analysis of the phase 3 CONVERT trial. J Thorac Oncol. 2018 Oct;13(10):S796-S797.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2018.08.1391Additional Links
https://dx.doi.org/10.1016/j.jtho.2018.08.1391Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2018.08.1391